Arkolith/Insider Trading/PNT/Form 4

Fleshner Neil E.

Chief Medical Officer, DirectorPOINT Biopharma Global Inc. (PNT) · full profile →Form 4 · filed May 26, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.2M
Net Open-Market Flow
-$4.2M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2022Sell(S)564K$7.51$4.2M3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-065250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML